MCI’s Lemonade Stand series tackles ethics of male contraceptives, clinical trials, and more

The Male Contraceptive Initiative launched their “Lemonade Stand” discussion series as a way to bring the male contraception research community together in a virtual space during the COVID-19 pandemic, “making lemons into lemonade by connecting and sharing.”

So far, the webinar series has covered a variety of emerging questions from the field to drive the advancement of male contraception from clinical trials to market, including the regulatory process, manufacturing process, and multipurpose prevention technologies (MPTs). Stay tuned for ongoing conversations.

Missed a previous discussion? Check out the recordings:

• Chemistry, Manufacturing, & Controls (CMC) with Lex Smith, ADS Pharma Consulting, LLC

• Male Contraceptive's Regulatory & Clinical Trial Issues with Dr. Diana Blithe, NICHD & Dr. Lisa Rarick, RAR Consulting, LLC

• Multipurpose Prevention Technologies (MPTs) & Male Contraception with Dr. Bethany Young Holt, CAMI Health

• "Shared Risk” and the Ethics of Male Contraception with Dr. Georgina Campelia, Carmen Abbe, Evy McElmeel, and Dr. John Amory

• The Funding Landscape of Male Contraceptive Research & Development with Maya Goldstein, Policy Cures Research [Note the G-FINDER reports for 2020 (discussed in the conversation) and 2014 can also be found in the CTI Exchange Resource Library.]

• Reproductive Aging and Building a Consortium with Bevin Lin and Jennifer Garrison, the Buck Institute

• Considering the Future - The Impact & Implementation of Youth Advisory Boards in Male Contraception with the Male Contraceptive Initiative (MCI) Youth Advisory Board, led by Connie Dean

• Triptonide as a Non-Hormonal Male Contraceptive with Dr. Wei Yan

• Male Contraception: Understanding People’s Needs & Wants through Market Research with Steve Kretschmer

• Male Contraceptive Delivery Modalities with Jennifer Ayres from FHI 360, Rahima Benhabbour from AnelleO, Brian Nguyen from USC, and Mark Saltzman from Yale

Stay tuned for information about the next conversation!